| | Identification | More |  | [Name] 
 1-[4-(TRIFLUOROMETHYL)PHENYL]ETHANOL
 |  | [CAS] 
 1737-26-4
 |  | [Synonyms] 
 1-[4-(TRIFLUOROMETHYL)PHENYL]ETHAN-1-OL
 1-[4-(TRIFLUOROMETHYL)PHENYL]ETHANOL
 ALPHA-METHYL-4-(TRIFLUOROMETHYL)BENZYL ALCOHOL
 ALPHA-METHYL-P-(TRIFLUOROMETHYL)BENZYL ALCOHOL
 ALPHA-METHYL-4-(TRIFLUOROMETHYL) BENZYL ALCOHOL, TECH., 90%
 -Methyl-4-trifluoromethylbenzylalcohol
 à-methyl-4-(trifluoromethyl)benzyl alcohol
 A-METHYL-4-TRIFLUOROMETHYLBENZYL ALCOHOL
 1-4-(Trifluoromethyl)phenylüethanol, 97%
 1-(1-Hydroxyethyl)-4-(trifluoromethyl)benzene
 4-(Trifluoromethyl)-α-methylbenzyl alcohol
 α-Methyl-4-(trifluoromethyl)benzenemethanol
 α-Methyl-p-(trifluoromethyl)benzyl alcohol
 |  | [EINECS(EC#)] 
 642-857-9
 |  | [Molecular Formula] 
 C9H9F3O
 |  | [MDL Number] 
 MFCD00039618
 |  | [Molecular Weight] 
 190.16
 |  | [MOL File] 
 1737-26-4.mol
 | 
 | Chemical Properties | Back Directory |  | [Appearance] 
 clear colorless to pale yellow liquid
 |  | [Boiling point ] 
 106-107 °C8 mm Hg(lit.)
 
 |  | [density ] 
 1.237 g/mL at 25 °C(lit.)
 
 |  | [refractive index ] 
 n20/D 1.458(lit.)
 
 |  | [Fp ] 
 209 °F
 
 |  | [storage temp. ] 
 Sealed in dry,Room Temperature
 |  | [pka] 
 13.98±0.20(Predicted)
 |  | [Specific Gravity] 
 1.2371.249
 |  | [BRN ] 
 2257808
 |  | [InChI] 
 InChI=1S/C9H9F3O/c1-6(13)7-2-4-8(5-3-7)9(10,11)12/h2-6,13H,1H3
 |  | [InChIKey] 
 YMXIDIAEXNLCFT-UHFFFAOYSA-N
 |  | [SMILES] 
 C1(C(F)(F)F)C=CC(C(O)C)=CC=1
 |  | [CAS DataBase Reference] 
 1737-26-4(CAS DataBase Reference)
 | 
 | Safety Data | Back Directory |  | [Hazard Codes ] 
 Xi,F
 |  | [Risk Statements ] 
 R36/37/38:Irritating to eyes, respiratory system and skin .
 |  | [Safety Statements ] 
 S24/25:Avoid contact with skin and eyes .
 |  | [WGK Germany ] 
 3
 
 |  | [Hazard Note ] 
 Irritant
 |  | [HazardClass ] 
 FLAMMABLE
 |  | [HS Code ] 
 2906290090
 | 
 | Hazard Information | Back Directory |  | [Chemical Properties] 
 clear colorless to pale yellow liquid
 |  | [Uses] 
 1-[4-(TrifluoroMethyl)phenyl]ethanol is used as an important pharmaceutical intermediate of a chemokine CCR5 antagonist.
 | 
 |  |